Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyoko Kaji

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Ryoikibetsu Shokogun Shirizu|July 25, 2003
[Double depression]Kyoko Kaji, Reiji Yoshimura, Jun Nakamura
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 4, 2006
Risperidone in the treatment of psychotic depressionMakiko Goto, Reiji Yoshimura, Shingo Kakihara, et al.
International Clinical Psychopharmacology|February 25, 2005
Prediction of response to risperidone treatment with respect to plasma concencentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6Shingo Kakihara, Reiji Yoshimura, Koji Shinkai, et al.
Human Psychopharmacology|April 15, 2005
An open study of risperidone liquid in the acute phase of schizophreniaReiji Yoshimura, Jun Nakamura, Koji Shinkai, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Ryoikibetsu Shokogun Shirizu|July 25, 2003
[Double depression]Kyoko Kaji, Reiji Yoshimura, Jun Nakamura
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 4, 2006
Risperidone in the treatment of psychotic depressionMakiko Goto, Reiji Yoshimura, Shingo Kakihara, et al.
International Clinical Psychopharmacology|February 25, 2005
Prediction of response to risperidone treatment with respect to plasma concencentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6Shingo Kakihara, Reiji Yoshimura, Koji Shinkai, et al.
Human Psychopharmacology|April 15, 2005
An open study of risperidone liquid in the acute phase of schizophreniaReiji Yoshimura, Jun Nakamura, Koji Shinkai, et al.
Pageof 1